A market in flux requires adaptive strategies for successful access and reimbursement. Attend this dynamic industry event that brings together manufacturers, public and private payers and clinicians.
Agenda at a Glance
Wednesday, June 26, 2019 | 8:00 a.m. – 4:15 p.m. Main Conference – Featured Sessions Include- Dissecting National Pharmacare Frameworks: Assessing the Viability of a Single-Payer Public Drug System
- Preparing for the Anticipated PMPRB Pricing Reform: A Guide for Adapting to Modernized Pricing and Access Requirements
- Using International HTA Harmonization to Achieve Market Access
- Filling the Gaps with RWE: Supporting Access Decision-Making throughout the Product Life Cycle
- The Roadmap to pCPA Negotiations on Advanced Therapeutics
- Analyzing the Medical Marijuana Market and Reimbursement Regime in Canada
- Assessing the Potential for Access and Reimbursement of Biosimilars
- Opportunities to Get Your Product in the Access Fast Lane through Clinical Trials
- Developing Access and Reimbursement Infrastructure for CAR T-cell Therapy
- INESSS: Exploring Quebec’s Influence on Market Access and Reimbursement
- Pharmacogenomics: Driving Efficiencies Through Value based Patient Solutions
- Exploring Cross-Border Perspectives on Pricing Pressures and Market Access
- Building Better Pathways to Drugs for Rare Disease
- Engaging with an Evolving Private Payer Landscape
Download the brochure now to view the complete agenda and expert speaker faculty.